Is natural conception a valid option for HIV-serodiscordant couples?

Is natural conception a valid option for HIV-serodiscordant couples? Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Is natural conception a valid option for HIV-serodiscordant couples? Abstract Text:

Pablo Barreiro, Castilla,Pablo Labarga,Vincent Soriano,

The remarkable reduction in HIV-related morbidity and mortality as a consequence of the widespread use of highly active antiretroviral therapy (HAART) has led to a growing number of HIV-infected persons and their partners requesting counselling regarding the chances of reproduction. A thoughtful medical evaluation of the couple, which should entail HIV status, screening for genital infections and fertile potential, is needed before considering any reproductive attempt. Given that both sexual and perinatal transmission of HIV is directly correlated with the level of viral replication, being almost negligible in patients with undetectable viremia, HAART should be given to the infected partner to minimize the risk of transmission. Assisted reproduction after 'sperm washing' may further reduce the chances of infection, although this is not within reach or desire for a significant number of HIV-serodiscordant couples. From our perspective, natural conception could now be considered a possible alternative for HIV-serodiscordant couples, as long as complete suppression of viremia with HAART is achieved in the infected partner. The objective of this paper is to propose a protocol that may minimize risks in HIV-discordant couples that have opted for natural conception.

Is natural conception a valid option for HIV-serodiscordant couples? Publishing Authors By Initials

P Barreiro,JA Castilla,P Labarga,V Soriano,

For similar reproductive and urinary physiology: reproduction research abstracts see: reproductive and urinary physiology: reproduction research

PUBMED ID PMID:

MEDLINE DATE:

Is natural conception a valid option for HIV-serodiscordant couples? Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Human reproduction (Oxford, England)

VOLUME: 22

Page Numbers: 2353-8

Journal Abbreviation: Hum. Reprod.

ISSN: 0268-1161

DAY: 19

MONTH: 07

YEAR: 2007

Is natural conception a valid option for HIV-serodiscordant couples? Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8701199

Is natural conception a valid option for HIV-serodiscordant couples? Keywords Mesh Terms:

KEYWORDS: Reproduction

MESH TERMS: ethics

Chemical & Substance for Abstract: Is natural conception a valid option for HIV-serodiscordant couples? Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Is natural conception a valid option for HIV-serodiscordant couples?

AFFILIATION: Department of Infectious Diseases, Hospital Carlos III, Calle Sinesio Delgado 10, 28029 Madrid, Spain. pm.barreiro@gmail.com

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Hum Reprod

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Is natural conception a valid option for HIV-serodiscordant couples? Related Publications

• Amino acid conservation in the gp41 transmembrane protein and natural polymorphisms associated with enfuvirtide resistance across HIV-1 variants.
• Conventional therapy of psoriatic arthritis: evidence-based review.
• Dynamics of drug-resistant HIV-1 in plasma and peripheral blood cells in patients during and after enfuvirtide therapy.
• Efficacy and safety of a once daily regimen with efavirenz, lamivudine, and didanosine, with and without food, as initial therapy for HIV Infection: the ELADI study.
• Ephrin-B2 forward signaling regulates somite patterning and neural crest cell development.
• Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis.
• Hospital-based surveillance for HTLV-1/2 infections in Spain.
• Immunizations in HIV-infected adults.
• Impact of baseline protease genotype and phenotype on the response to darunavir outside clinical trials.
• In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains.
• Inhibition of gap junction communication at ectopic Eph/ephrin boundaries underlies craniofrontonasal syndrome.
• Initial spontaneous clearance and re-infection with a distinct hepatitis C virus genotype leading to chronic hepatitis C in an HIV+ intravenous drug user.
• Is natural conception a valid option for HIV-serodiscordant couples?
• Pneumococcal LytA autolysin, a potent therapeutic agent in experimental peritonitis-sepsis caused by highly beta-lactam-resistant Streptococcus pneumoniae.
• Prevalence and impact of HIV-1 protease mutation L76V on lopinavir resistance.
• Prevalence of darunavir resistance mutations in HIV-1-infected patients failing other protease inhibitors.
• Prevalence of etravirine (TMC-125) resistance mutations in HIV-infected patients with prior experience of non-nucleoside reverse transcriptase inhibitors.
• Psychologically inspired anticipation and dynamic response for impacts to the head and upper body.
• Reelin and mDab1 regulate the development of hippocampal connections.
• Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial.
• The implications of antiviral drugs with activity against hepatitis B virus and HIV.
• Treatment of chronic hepatitis B in HIV-infected patients in 2007.
• Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.
• [Antiviral therapy according to HIV type and subtype.]
• [Clinical significance of the antimicrobial resistance of biofilms]
• [HIV-2 infection and human lymphotropic type 1 and type 2 virus in Spain]
• [Not Available.]
• [Not Available.]
• [Stavudine in antiretroviral therapy]
• [Treatment of chronic hepatitis B in HIV-positive patients.]